AKER News Alert Akers Biosciences (AKER) 3.13 11/13/2014 17:

New Post Public Reply Private Reply Replies (0) Message Board

Nov 13, 2014 at 6:28 PM

Akers Biosciences (AKER) 3.13 $AKER

Akers Biosciences Net Loss of $1.12M
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 6:18AM CST

AKER: 3.13 (+0.22)

Akers Biosciences Announces Its Financial Results for Third Quarter 2014
GlobeNewswire - Thu Nov 13, 6:05AM CST
Akers Biosciences, Inc. (Nasdaq:AKER), (the "Company" or "ABI"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, reports its financial results for the third quarter ended September 30, 2014 and for the nine months ended September 30, 2014. The Form 10-Q containing the financial statements is available for viewing on the Company's website at www.akersbiosciences.com or www.sec.gov.
AKER: 3.13 (+0.22)

Akers Biosciences Announces Conference Call to Discuss Its Third Quarter and Nine Months Financial Results
GlobeNewswire - Mon Nov 10, 6:07AM CST
Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the "Company" or "ABI"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, will hold a conference call on Thursday, November 13, 2014, at 10:30 a.m. Eastern Time to discuss its results for the third quarter and nine months ended September 30, 2014.
AKER: 3.13 (+0.22)

The Perils Of Value Microcap Research And The Example Of Akers Biosciences
Daniel Ward - at Seeking Alpha - Tue Nov 04, 12:22PM CST

AKER: 3.13 (+0.22)

Week In Review: Roche Seeks China Partners With First-In-Class, Best-In-Class Products
ChinaBio Today - at Seeking Alpha - Sun Oct 26, 12:46PM CDT
Featured Companies In an exclusive interview, Dr. Darren Ji (Vice President and Global Head of Roche Partnering, Asia and Emerging Markets) told ChinaBio Today that Roche ( OTCQX:RHHBY ) ( OTCPK:RHHBF ) remains entirely focused on novel drugs for...
FMI: 24.95 (-0.15), AKER: 3.13 (+0.22), WX: 37.13 (-1.35)

Akers Biosciences Announces Joint Venture to Market Rapid Diagnostic Tests in China
GlobeNewswire - Thu Oct 23, 7:17AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "Akers"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, has signed a Joint Venture Agreement (the "Joint Venture Agreement"

with Hainan Savy Investment Management Ltd ("Hainan"

and Mr. Thomas Knox ("Thomas Knox"

, the Company's Non-executive Co-Chairman (Akers, Hainan and Thomas Knox together the "Parties"

, to research, develop, produce and sell certain Akers' rapid diagnostic screening and testing products in China (the "Joint Venture"

. The Joint Venture Company will be located in Haikou, the capital city of the province of Hainan, China, and is incorporated as Hainan Savy Akers Biosciences, Ltd.
AKER: 3.13 (+0.22), AKR: 31.82 (+0.01)

NETGEAR, Akers Biosciences, and TOP Ships to Appear on RedChip TV on Bloomberg
GlobeNewswire - Wed Oct 08, 10:46AM CDT
RedChip Companies, Inc. ("RedChip"

, an international small-cap research, investor relations, and media company, today announced that "The RedChip Money Report: Small Stocks Big Money"

TM) television program is featuring interviews with NETGEAR (Nasdaq:NTGR), Akers Biosciences (Nasdaq:AKER), and TOP Ships (Nasdaq:TOPS) this week on Bloomberg television.
TOPS: 1.66 (-0.03), AKER: 3.13 (+0.22), NTGR: 34.29 (-0.23)

Akers Biosciences Features on Global Broadcast & Online Media
GlobeNewswire - Tue Sep 16, 11:45AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), a leading designer and manufacturer of rapid diagnostic screening and testing products, announces that its Executive Chairman, Raymond F. Akers Jr., Ph.D, was featured on "The RedChip Money Report: Small Stocks Big Money" television program which was televised on Fox Business nationwide as well as Bloomberg Europe, UK and Asia. A recording of the globally transmitted interview regarding Akers Biosciences' business can be viewed here: http://youtu.be/5ymviBu1kno.
AKER: 3.13 (+0.22)

Police and Employers May Finally See Cannabis Breathalyzer
ACCESSWIRE - Wed Sep 10, 8:47AM CDT
Whitefish, MT / September 10, 2014 / The gradual proliferation of alcohol breathalyzer technology has helped bring down the per unit price so far that professional-grade technology, like the kind developed by Akers Biosciences, Inc. (NASDAQ: AKER), is now being marketed directly to consumers. Touted as a safety measure, as well as a means of avoiding the high cost and complications of a DUI/DWI, alcohol breathalyzers are becoming a proactive tool, used by consumers to help them more confidently enjoy an intoxicating product on their own terms.
AKER: 3.13 (+0.22), BED.VN: 0.800 (+0.010), TWD.VN: 2.520 (-0.120)

RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg
GlobeNewswire - Tue Sep 09, 1:34PM CDT
RedChip Companies, Inc. ("RedChip"

, an international small-cap research, investor relations, and media company, today announced that "The RedChip Money Report: Small Stocks Big Money"

TM) television program will feature three companies on Fox Business nationwide on Tuesday, September 9 at 10:00 p.m. Pacific (1 a.m. EDT). The show will also air on Bloomberg Europe on Sunday, September 14 at 8:30 a.m. and 3:30 p.m. GMT; on Bloomberg U.K. Sunday, September 14 at 5:00 p.m. and 8:30 p.m. GMT; and on Bloomberg Asia on Sunday September 14 at 3:30 p.m. HKT.
IQNT: 18.51 (-0.11), AKER: 3.13 (+0.22)

Akers Biosciences Presenting at US Investor Conferences
GlobeNewswire - Tue Sep 09, 12:43PM CDT
Executive Chairman Raymond F. Akers Jr., Ph.D, to present at:
AKER: 3.13 (+0.22)

Akers Biosciences Announces $864,000 Sales Contract for Its Rapid Results Point of Care Cholesterol Test
GlobeNewswire - Tue Sep 09, 6:30AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the "Company" or "ABI"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, announced a contract valued at $864,000 for sales of its innovative Tri-Cholesterol "Check" tests in Australia, Singapore, the United Arab Emirates and Oman. The Company's products are being distributed in such regions by 36 Strategies General Trading LLC ("36S"

, a Dubai-based procurement solutions company. Target customers in Australia, Singapore, the United Arab Emirates and Oman include military forces, medical associations, universities and large companies operating in the resources sector.
AKER: 3.13 (+0.22)

RedChip Issues Research Update on Akers Biosciences
GlobeNewswire - Mon Aug 18, 9:10AM CDT
RedChip Companies, Inc., today announced it has issued a research update on Akers Biosciences Inc. (Nasdaq:AKER), a leading designer and manufacturer of rapid diagnostic screening and testing products.
AKER: 3.13 (+0.22)

Akers Biosciences Reports Its Second Quarter Financial Results
GlobeNewswire - Tue Aug 12, 6:09AM CDT
Sales of flagship PIFA Heparin/PF4 products increasing
AKER: 3.13 (+0.22)

Akers Biosciences Announces Conference Call to Discuss Its Second Quarter and Six Months Financial Results
GlobeNewswire - Mon Aug 11, 11:17AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the "Company" or "ABI"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, will hold a conference call on Tuesday, August 12, 2014, at 10:30 a.m. Eastern Time to discuss its results for the second quarter and six months ended June 30, 2014.
AKER: 3.13 (+0.22)

Akers Appoints New Vice President of International Sales and Marketing to Build International Business
GlobeNewswire - Tue Aug 05, 1:00AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "Akers"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, announces the appointment of Nicolas Daurel as Vice President of International Sales and Marketing for Europe, the Middle East and Africa ("EMEA"

. Mr. Daurel has a twenty year track-record of successfully building and managing the sales of medical devices in EMEA, particularly within the coagulation sector.
AKER: 3.13 (+0.22), AKR: 31.82 (+0.01)

Akers Biosciences Signs Feasibility Study Deal With Konica Minolta to Develop Rapid Test to Aid Heart Attack Diagnoses
GlobeNewswire - Mon Jul 28, 1:00AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "Akers"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, has signed a feasibility study deal with Konica Minolta, Inc. ("Konica Minolta"

to develop a rapid test for the early detection of cardiac muscle tissue damage - a condition commonly observed in patients suffering myocardial infarction (heart attacks). Heart attacks are the leading cause of death in U.S, with approximately 1.1 million Americans suffering heart attacks each year.
AKER: 3.13 (+0.22), AKR: 31.82 (+0.01)

US Patent Granted for Akers' Breath Ketone Detection Device
GlobeNewswire - Thu Jul 17, 1:00AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "Akers"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, announces that the United States Patent and Trademark Office ("USPTO"

has granted a patent covering Akers' Breath Ketone detection device.
AKER: 3.13 (+0.22), AKR: 31.82 (+0.01)

Akers to Ring Today's NASDAQ Closing Bell
GlobeNewswire - Wed Jul 09, 7:09AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "ABI"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, is pleased to announce that the Company's Board of Directors, led by Raymond F. Akers Jr., Ph.D., Co-founder and Executive Chairman, will ring The NASDAQ Closing Bell this afternoon in celebration of Akers' January 23, 2014 listing on The NASDAQ Capital Market.
AKER: 3.13 (+0.22), AKR: 31.82 (+0.01), NDAQ: 43.79 (-0.24)

RedChip Issues Research Profile on Akers Biosciences
GlobeNewswire - Tue Jul 08, 9:03AM CDT
RedChip Companies, Inc., today announced it has issued a research profile on Akers Biosciences Inc. (Nasdaq:AKER), a leading designer and manufacturer of rapid diagnostic screening and testing products.
AKER: 3.13 (+0.22)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

FirstService Unveils New LA Luxury Living Insights

Fresh Insights from Los Angeles' Vertical Living Scene FirstService Residential is throwing the spotlight on luxury high-rises in Los Angeles with their latest episode of Skyline Sessions. Catching wind of this release feels like getting the inside scoop from the horse's mouth—it's about the finer points shaping posh city living in a bustling Californian metropolis....

Landstar Faces Legal Storm Post Earnings Miss

Landstar's Earnings Misstep Sends Shockwaves Alright, let's talk about this snafu at Landstar (NASDAQ: LSTR). They were supposed to deliver an earnings sheet that's all roses, but instead, we got a couple of thorns. Analysts were expecting them to strike gold with EPS numbers between $1.62 to $1.67. What we got? A measly $1.42. Not exactly the shiny haul we were led to...

Jack Henry's Q1 2027 Deconversion Revenue Hits $17.9M

Jack Henry Surprises with Strong Deconversion Revenue You're probably thinking, deconversion revenue—what on earth is that? Imagine you're in the financial tech business and one of your bigwig clients decides to merge or get gobbled up by another institution. They move shop, and voila, you've got some unexpected money flowing in due to that exit. That's deconversion...

Bambusa Therapeutics: IPO Priced At $16, Shares On Nasdaq

How Does Bambusa Therapeutics Stack Up? Well, here we go again in the biotech bonanza, folks. Bambusa Therapeutics is stepping onto the stage with their shiny new upsized IPO, offering a whopping 10,555,555 shares at sixteen bucks a pop. That's real money, coming in at $168,888,880 in gross proceeds if everything goes according to plan. Seems like a hefty sum, but in this...

WHI's Nexus AI Transforms Phone Ordering in Parts Biz

Nexus AI: The New Frontline for Part Distributors In a move poised to shake up the auto parts distribution scene, WHI Solutions, a child of eBay, is rolling out a game-changer: the Nexus AI suite designed for the Nexpart platform. Now, tech and tradition blend as AI tackles phone ordering for those early-morning rushes and late-night calls. A Solution for Your Busiest...

AndX Global Launches $100M Tokenized Manila Project

Revolutionizing Real Estate Investment AndX Global is blazing a new trail in the real estate market with the introduction of Manila One, the world's first comprehensive tokenized land development. It's a hundred-million-dollar bet—a nod to the future of cross-border investing, and it screams opportunity for those ready to roll the dice in this new arena. The Mechanics...

Palmetto Publishing's M&A Guide Aims to Boost Home Services

Palmetto's New Release: Mergers & Acquisitions Focus Man, Palmetto Publishing just dropped a bombshell for home services aficionados with their latest M&A guide. Now, if you’re like me, swimming in stocks and always looking for that next big exit play, this one’s tailor-made for you. Mergers and acquisitions might not sound as flashy as the tech darlings or...

Transforming Healthcare Leadership Through Systemic Change

Reframing Physician Leadership for Systemic Transformation Here we go, diving into some serious change-making in the healthcare sphere. If you've ever wandered through a hospital corridor, you've likely felt the tension between docs and the suits. The American Association for Physician Leadership (AAPL) is stirring the pot with a fresh book that might just be the catalyst...

Xerox Faces Probes After $130M Profit Forecast Slash

When the Trust Breaks October 29, 2026 was a gut punch for Xerox investors. Watching the outlook dive by $130 million, the coffee-feeling in the trading rooms turned into something more bitter. A $105 million boost they once celebrated from tariff receivables now seems to be a fleeting shadow, as Xerox itself scuttles its adjusted operating income for 2026 to a range of...

Jereh Saturn Gensets: Powering a New Era in Energy

Why Jereh Saturn Is a Game-Changer Imagine cutting down months, if not years, of setup time in a sector that's notoriously slow-moving. That's exactly what Jereh’s new Saturn Modular Gas Gensets promise. Rolled out in Yantai, China, these power units are all about efficiency and speed—right off the bat they bring immediate juice to oil and gas fields as well as...